Đang chuẩn bị liên kết để tải về tài liệu:
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

Ovarian low-grade serous carcinoma (LGSC) has fewer mutations than ovarian high-grade serous carcinoma (HGSC) and a less aggressive clinical course. However, an overwhelming majority of LGSC patients do not respond to conventional chemotherapy resulting in a poor long-term prognosis comparable to women diagnosed with HGSC. KRAS and BRAF mutations are common in LGSC, leading to clinical trials targeting the MAPK pathway. |